You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 11, September 15, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (74)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Rheumatology
 •Osteoporosis
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Use of {beta}-Blockers and Risk of Fractures

Raymond G. Schlienger, PhD, MPH; Marius E. Kraenzlin, MD; Susan S. Jick, DSc; Christoph R. Meier, PhD, MSc

JAMA. 2004;292:1326-1332.

Context  Animal studies suggest that the {beta}-blocker propranolol increases bone formation, but data on whether use of {beta}-blockers (with or without concomitant use of thiazide diuretics) is associated with reduced fracture risk in humans are limited.

Objective  To determine whether use of {beta}-blockers alone or in combination with thiazides is associated with a decreased risk of fracture in adults.

Design, Setting, and Participants  Case-control analysis using the UK General Practice Research Database (GPRD). The study included 30 601 case patients aged 30 to 79 years with an incident fracture diagnosis between 1993 and 1999 and 120 819 controls, matched to cases on age, sex, calendar time, and general practice attended.

Main Outcome Measures  Odds ratios (ORs) of having a fracture in association with use of {beta}-blockers or a combination of {beta}-blockers with thiazides.

Results  The most frequent fractures were of the hand/lower arm (n = 12 837 [42.0%]) and of the foot (n = 4627 [15.1%]). Compared with patients who did not use either {beta}-blockers or thiazide diuretics, the OR for current use of {beta}-blockers only (≥3 prescriptions) was 0.77 (95% confidence interval [CI], 0.72-0.83); for current use of thiazides only (≥3 prescriptions), 0.80 (95% CI, 0.74-0.86); and for combined current use of {beta}-blockers and thiazides, 0.71 (95% CI, 0.64-0.79). Data were adjusted for smoking; body mass index; number of practice visits; and use of calcium channel blockers, angiotensin-converting enzyme inhibitors, antipsychotics, antidepressants, statins, antiepileptics, benzodiazepines, corticosteroids, and estrogens.

Conclusions  Our data suggest that current use of {beta}-blockers is associated with a reduced risk of fractures, taken alone as well as in combination with thiazide diuretics. Many elderly patients with hypertension who are at risk of developing osteoporosis may potentially benefit from combined therapy with {beta}-blockers and thiazides.


Author Affiliations: Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology (Drs Schlienger and Meier) and Division of Endocrinology, Diabetes and Clinical Nutrition (Dr Kraenzlin), University Hospital, and Institute of Clinical Pharmacy, Department of Pharmaceutical Sciences, University of Basel (Drs Schlienger and Meier), Basel, Switzerland; and Boston Collaborative Drug Surveillance Program, Boston University, School of Medicine, Lexington, Mass (Drs Jick and Meier).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hip fractures and heart failure: findings from the Cardiovascular Health Study
Carbone et al.
Eur Heart J 2009;0:ehp483v1-ehp483.
ABSTRACT | FULL TEXT  

Mice Lacking {beta}-Adrenergic Receptors Have Increased Bone Mass but Are Not Protected from Deleterious Skeletal Effects of Ovariectomy
Bouxsein et al.
Endocrinology 2009;150:144-152.
ABSTRACT | FULL TEXT  

Heart Failure Is a Risk Factor for Orthopedic Fracture: A Population-Based Analysis of 16 294 Patients
van Diepen et al.
Circulation 2008;118:1946-1952.
ABSTRACT | FULL TEXT  

Angiotensin II accelerates osteoporosis by activating osteoclasts
Shimizu et al.
FASEB J. 2008;22:2465-2475.
ABSTRACT | FULL TEXT  

Use of Thiazolidinediones and Fracture Risk
Meier et al.
Arch Intern Med 2008;168:820-825.
ABSTRACT | FULL TEXT  

Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture
Richards et al.
Arch Intern Med 2007;167:188-194.
ABSTRACT | FULL TEXT  

Dose Effects of Propranolol on Cancellous and Cortical Bone in Ovariectomized Adult Rats
Bonnet et al.
J. Pharmacol. Exp. Ther. 2006;318:1118-1127.
ABSTRACT | FULL TEXT  

Risk of Osteoporotic Fracture in Elderly Patients Taking Warfarin: Results From the National Registry of Atrial Fibrillation 2
Gage et al.
Arch Intern Med 2006;166:241-246.
ABSTRACT | FULL TEXT  

Effects of a {beta}-Blocker on Bone Turnover in Normal Postmenopausal Women: A Randomized Controlled Trial
Reid et al.
J. Clin. Endocrinol. Metab. 2005;90:5212-5216.
ABSTRACT | FULL TEXT  

Good vibrations and strong bones?
Jordan
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005;288:R555-R556.
FULL TEXT  

Is Menopause Getting on Your Nerves?
Ducy
IBMS BoneKEy 2005;2:11-13.
FULL TEXT  

Do Beta-Blockers and Thiazides Reduce Fracture Risk?
Journal Watch Cardiology 2004;2004:4-4.
FULL TEXT  

Clinical and Basic Research Papers - August 2004 Selections
Seeman and Strewler
IBMS BoneKEy 2004;1:1-3.
FULL TEXT  

Can {beta}-Blockers and Thiazides Reduce Risk for Fractures?
JWatch General 2004;2004:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.